Clover Health Files 8-K for Bylaw Amendments & Exhibits
Ticker: CLOV · Form: 8-K · Filed: Jun 25, 2024 · CIK: 1801170
| Field | Detail |
|---|---|
| Company | Clover Health Investments, Corp. /De (CLOV) |
| Form Type | 8-K |
| Filed Date | Jun 25, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing, financial-reporting
Related Tickers: CLOV
TL;DR
CLOV filed an 8-K for bylaw changes and financial docs. Nothing major revealed yet.
AI Summary
Clover Health Investments Corp. filed an 8-K on June 25, 2024, reporting events as of June 19, 2024. The filing primarily concerns amendments to its articles of incorporation or bylaws and the submission of financial statements and exhibits. No specific financial figures or new material events were detailed in the provided excerpt.
Why It Matters
This filing indicates administrative updates and the submission of required financial documentation, which are standard corporate governance procedures.
Risk Assessment
Risk Level: low — The filing appears to be routine administrative and financial reporting, not indicating any immediate material adverse events.
Key Players & Entities
- CLOVER HEALTH INVESTMENTS, CORP. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- 3401 Mallory Lane, Suite 210 Franklin, Tennessee 37067 (address) — Principal Executive Offices
FAQ
What specific amendments were made to Clover Health's articles of incorporation or bylaws?
The provided excerpt does not detail the specific amendments made to the articles of incorporation or bylaws.
What financial statements and exhibits were filed with this 8-K?
The excerpt states that financial statements and exhibits were filed, but does not list their specific contents.
What is the date of the earliest event reported in this 8-K?
The earliest event reported in this 8-K is dated June 19, 2024.
What is Clover Health's fiscal year end?
Clover Health's fiscal year end is December 31.
What is the SEC file number for Clover Health Investments, Corp.?
The SEC file number for Clover Health Investments, Corp. is 001-39252.
Filing Stats: 495 words · 2 min read · ~2 pages · Grade level 10.9 · Accepted 2024-06-25 16:05:43
Key Financial Figures
- $0.0001 — stered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market
Filing Documents
- clov-20240619.htm (8-K) — 27KB
- exhibit31-secondamendedand.htm (EX-3.1) — 227KB
- 0001801170-24-000135.txt ( ) — 431KB
- clov-20240619.xsd (EX-101.SCH) — 2KB
- clov-20240619_def.xml (EX-101.DEF) — 3KB
- clov-20240619_lab.xml (EX-101.LAB) — 25KB
- clov-20240619_pre.xml (EX-101.PRE) — 14KB
- clov-20240619_htm.xml (XML) — 3KB
03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.03. Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. On June 19, 2024, the Board of Directors of Clover Health Investments, Corp. (the "Company") unanimously adopted the Second Amended and Restated Bylaws of the Company (the "Bylaws"), effective immediately, in order to modify the definition of "Acting in Concert" contained therein. The foregoing summary does not purport to be complete and is qualified in its entirety by reference to the complete text of the Bylaws, which are attached hereto as Exhibit 3.1 and are incorporated herein by reference.
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) List of Exhibits Exhibit No. Description 3.1 Second Amended and Restated Bylaws of Clover Health Investments, Corp., effective as of June 19, 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL Document SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Clover Health Investments, Corp. Date: June 25, 2024 By: /s/Karen M. Soares Name: Karen M. Soares Title: General Counsel and Corporate Secretary